# A Comparative Post-marketing Study of Commercially Available Peripheral Nerve Gap Repair Options

> **NCT00948025** · NA · TERMINATED · sponsor: **Axogen Corporation** · enrollment: 23 (actual)

## Conditions studied

- Traumatic Nerve Injury

## Interventions

- **DEVICE:** Hollow tube nerve conduit, synthetic or biosynthetic
- **OTHER:** Processed Human Nerve Tissue

## Key facts

- **NCT ID:** NCT00948025
- **Lead sponsor:** Axogen Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-06
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 23 (ACTUAL)
- **Why stopped:** transitioning from 361 HCT/P Tissue to a Biologic (BLA)
- **Last updated:** 2020-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00948025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00948025, "A Comparative Post-marketing Study of Commercially Available Peripheral Nerve Gap Repair Options". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00948025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
